Link here. RNS Number : 1434H Rex Bionics PLC · 95% Treatment Success and no adverse events · 95% of volunteers said they would like to use REX on a weekly basis · Next new RAPPER II sites will be the Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK; and Austin Health: Royal Talbot Rehabilitation Centre, Melbourne, Australia 27 November […]
18 September, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, notes two recent legal settlements — awarding funding for the purchase of a REX robot and funding for Robot-Assisted Physiotherapy with REX. These developments help to establish an important principle – that individuals […]
20 July 2015, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users, is pleased to announce that it has today signed a new agreement for a partnership in China with MAAB Group, an investment and trading company that specialises in sourcing and introducing innovative […]
Placing and Subscription to raise £2.1 million and proposed Additional Fundraising to raise approximately £1.0 million and Share Restructuring. Link here. 12 June 2015 Rex Bionics Plc (AIM: RBX), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, today announces a proposed Placing and Subscription of 3,500,000 New Ordinary Shares at […]
1 June 2015 Rex Bionics Plc (AIM: RBX), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce that the first patient has been successfully treated in its RAPPER II (“Robot-Assisted PhysiotheraPy Exercises with REX”) clinical trial. Link here. A 37 year-old male with a spinal cord injury at level T3, […]
29 May 2015, Rex Bionics Plc (AIM: RXB) the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users and enables robot assisted physiotherapy exercise, today announces its audited results for the sixteen month period ending 31 March 2015. Link here.
By Nigel Roberts. April 28 2015. Link here. Crispin Simon, chief executive of Rex Bionics (LON:RXB), says the company’s robotic walking device is now attracting the attention of specialist rehabilitation clinics from around the world. ‘Now we do have distribution partners who are expert in the field of neuro-rehabilitation from all over the world who are now coming to […]
22 April 2015. Link here. Rex Bionics plc, the pioneer of the REX Robot technology that enhances the mobility of wheelchair users and Deltason Medical Ltd, a distributor of rehabilitation equipment in Hong Kong and China, are pleased to announce that they have signed a distribution agreement in which Deltason will exclusively represent REX in Hong […]
Link here. 2014 AIM WINNERS – Best Technology Award. Announced at the AIM Awards ceremony on 9 October 2014.
11 August 2014. Link here. Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces that its Auckland-based subsidiary Rex Bionics Ltd (RBL) has been awarded substantial new grant funding by the New Zealand Government to support the research and development of REX 3, the platform […]